Orchid Chem antibiotic gets USFDA nod

Chennai-based pharma major Orchid Chemicals & Pharmaceuticals today announced that it has received approval from the US FDA for its ANDA(Abbreviated New Drug Application) for Cefpodoxime Proxetil Tablets.

The product is available in 100mg and 200mg dosage strengths.

Cefpodoxime Proxetil is a 3rd generation cephalosporin antibiotic which has a broad spectrum activity against organisms causing infectious diseases.

With limited generic competition in this product, the company hopes to garner a sizeable market share and revenues in the US market.

Last month it launched two key antibiotic products, Cefepime and Cefdinir, in the US market, net profit of the company jumped 115% to Rs 63.27 crore for the quarter ended September 30, 2007, compared with Rs 29.45 crore recorded in the corresponding previous period last year.

The company achieved 20% higher turnover and operating income of Rs 295.12 crore (Rs 245.73 crore) for the quarter ended September 30, 2007.